Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BRTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 239K | $65K | +717.2% | 2.653% | 0.00% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 223K | $61K | +285.6% | 2.481% | 0.00% |
| 3 | UBS Group AG | 100K | $27K | β | 1.110% | 0.00% |
| 4 | Wealth Alliance | 40K | $11K | 0.0% | 0.445% | 0.00% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 39K | $11K | β | 0.439% | 0.00% |
| 6 | STATE STREET CORP | 32K | $9K | 0.0% | 0.361% | 0.00% |
| 7 | ADVISOR GROUP HOLDINGS, INC. | 2K | $540 | 0.0% | 0.022% | 0.00% |
| 8 | Tower Research Capital LLC (TRC) | 1K | $398 | +32.2% | 0.016% | 0.00% |
| 9 | SBI Securities Co., Ltd. | 199 | $54 | +67.2% | 0.002% | 0.00% |
| 10 | Rossby Financial, LCC | 11 | $3 | 0.0% | 0.000% | 0.00% |
| 11 | Cornerstone Planning Group LLC | 11 | $3 | +1000.0% | 0.000% | 0.00% |
| 12 | TD Waterhouse Canada Inc. | 3 | $1 | 0.0% | 0.000% | 0.00% |
| 13 | Caitong International Asset Management Co., Ltd | 1 | $0 | β | 0.000% | 0.00% |
| 14 | Parallel Advisors, LLC | 1 | $0 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in BRTX β a direct measure of their conviction.
Filings activity in BRTX during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new BRTX position in Q1 2026
Institutions that fully closed their BRTX position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 14 | 6.7% | 5.81% | 4.56 pp | $0M | 44% |
| Q4 2025 | 15 | 12% | 10.37% | 5.89 pp | $0M | 36% |
| Q3 2025 | 17 | 11% | 16.26% | +3.85 pp | $1M | +31% |
| Q2 2025 | 19 | +5.6% | 12.41% | 0.42 pp | $0M | 3.3% |
| Q1 2025 | 18 | +0.0% | 12.83% | +2.38 pp | $0M | +23% |
| Q4 2024 | 18 | +0.0% | 10.45% | 1.56 pp | $0M | 13% |
| Q3 2024 | 18 | +13% | 12.01% | 0.75 pp | $0M | 5.9% |
| Q2 2024 | 16 | β | 12.76% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BRTX stock.
Based on Q1 2026 13F filings, institutional ownership of BioRestorative Therapies, Inc. stands at 5.8%, held across 14 reporting institutions.
CITADEL ADVISORS LLC is the largest reported institutional holder of BRTX, with approximately 238,606 shares worth $0.00B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of BRTX, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for BRTX is 33 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in BRTX during Q1 2026, while 4 fully exited. 2 added to existing positions and 8 trimmed.
BRTX institutional ownership fell by 4.56 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 100.0% of all reported 13F value in BRTX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
BioRestorative Therapies, Inc. (BRTX) Institutional Ownership